AETERNUM HEALTH, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $203.7K | $65.1K | $20.1K | $5.0K | $0 | $0 | $0 | $13.9K |
| Cost of Revenue | — | $49.4K | $43.6K | — | — | — | — | — |
| Gross Profit | $120.1K | $-12.7K | $-33.0K | — | — | — | — | — |
| Gross Margin | 58.9% | -19.5% | -164.2% | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $105.3K | $99.8K | $335.5K | $229.5K | — | — | — | — |
| Operating Income | $-269.3K | $-430.5K | $-552.4K | $-304.0K | $-49.0K | $-59.9K | $-81.4K | $-83.6K |
| Operating Margin | -132.2% | -661.1% | -2,746.8% | -6,080.7% | — | — | — | -599.8% |
| Interest Expense | $67.8K | $69.8K | $80.6K | $1.7M | $3.5K | $1.2K | $1.8K | $5.7K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | $0 | — | — | — | — |
| Net Income | $-337.1K | $-450.3K | $-632.9K | $-2.1M | $-52.5K | $-61.1K | $-83.2K | $103.6K |
| Net Margin | -165.5% | -691.5% | -3,147.6% | -41,467.8% | — | — | — | 743.4% |
| EPS (Basic) | $-0.01 | $-0.01 | $-0.01 | $-0.05 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.05 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 49.0M | 48.5M | 42.5M | 40.3M | 24.6M | 24.6M | 24.6M | 24.6M |
| Shares Outstanding (Diluted) | 49.0M | 48.5M | 42.5M | 40.3M | 24.6M | 24.6M | 24.6M | 32.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |